Vivo Capital
VOR icon

Vivo Capital’s Vor Biopharma VOR Stock Holding History

Vivo Capital’s Portfolio VOR Stock Details VOR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$10.5M Buy
+550,358
New +$11.7M 1.16% 27

Other funds holding VOR

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.32T AUM 44.66% 1-Year Est. Return
BlackRock
BlackRock New York $6.79T AUM 37.06% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.76T AUM
State Street
State Street Boston, Massachusetts $3.44T AUM 36.12% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $71.4B AUM 33.43% 1-Year Est. Return
Nan Fung Trinity
Nan Fung Trinity Central, Hong Kong, Hong Kong $1.04B AUM 32.17% 1-Year Est. Return
NEXTBio Capital Management
NEXTBio Capital Management Menlo Park, California $234M AUM 176.49% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $765B AUM 28.39% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $474B AUM 32.39% 1-Year Est. Return

Vivo Capital's VOR Position: Q3 2026 in Review

Vivo Capital opened a new position in Vor Biopharma (VOR) in Q3 2026: 550,358 shares worth $10.5M. The stake represents 1.16% of the portfolio and ranks #27 among its holdings.

95 funds tracked by Wall St. Rank hold VOR as of Q3 2026.

  • Vivo Capital held 550,358 shares of Vor Biopharma worth $10.5M as of Q3 2026.
  • Vor Biopharma was a new Vivo Capital position in Q3 2026.
  • Vor Biopharma made up 1.16% of Vivo Capital's portfolio in Q3 2026, its #27 holding.
  • 95 funds tracked by Wall St. Rank held Vor Biopharma as of Q3 2026.

Based on Vivo Capital's 13F filing for Q3 2026, filed 13 Nov 2026.